A prospective observational study of estimating drug related problems and clinical outcomes in subtypes of stroke patients.
Muhammad AliMuhammad Harris ShoaibShagufta NesarMuhammad JamalSabiha GulSaira ShahnazShoaib NawazQuratulain KhanJavaria ImranPublished in: PloS one (2024)
This study helped determine DRPs along with various clinical factors affecting the clinical end outcomes of patients suffering from any clinical subtype of stroke. Due to the enhancement in the evidence of the incidence of DRPs in tertiary care hospitals, pharmacist-led drug therapy review by interfering with doctors and other medical professionals at the patient bed site is needed and should be done to avoid any negative end outcomes and serious issues related to DRPs.
Keyphrases
- healthcare
- tertiary care
- end stage renal disease
- ejection fraction
- mental health
- newly diagnosed
- chronic kidney disease
- atrial fibrillation
- prognostic factors
- risk factors
- stem cells
- type diabetes
- emergency department
- drug induced
- adipose tissue
- peritoneal dialysis
- skeletal muscle
- patient reported
- replacement therapy